United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $450.86, for a total value of $1,803,440.00. Following the completion of the sale, the chief executive officer directly owned 130 shares of the company's stock, valued at $58,611.80. The trade was a 96.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
United Therapeutics (NASDAQ:UTHR) CEO Sells $1,803,440.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $450.86, for a total value of $1,803,440.00. Following the completion of the sale, the chief executive officer directly owned 130 shares of the company's stock, valued at $58,611.80. The trade was a 96.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.